Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Nathan C. Resisting antimicrobial resistance. Nat Rev Microbiol. 2020;18(5):259-260.

Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, et al. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020;136(11):1284-1297.

Baloni P, Dinalankara W, Earls JC, Knijnenburg TA, Geman D, Marchionni L, et al. Identifying Personalized Metabolic Signatures in Breast Cancer. Metabolites. 2020;11(1).

Shah MA, Mayer S, Emlen F, Sholle E, Christos P, Cushing M, et al. Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer. JAMA Netw Open. 2020;3(9):e2023121.

Magro C, Cheng E, Kline MA, Belsito DV, Goldman B, Varghese M, et al. Follicular psoriasis: a report of 5 cases and review of the literature, likely an under-recognized yet distinctive variant of psoriasis. Dermatol Online J. 2020;26(7).

de Paz AM, Josefowicz SZ. Gene regulatory networks STARR-ing B cells. Nat Immunol. 2020;21(2):110-112.

Liang H, Wang Q, Wang D, Zheng H, Kalvakolanu DV, Lu H, et al. RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7. Biochem Pharmacol. 2020;180:114118.

Chung EY, McIlroy K, Fung C, Seshan SV, Moran S, Coleman PL. Glomerular, Mesangial, and Tubular Cytoplasmic Fibrillary Inclusions in a Patient with Light-Chain Proximal Tubulopathy. Nephron. 2020;144(4):190-194.

Droll SH, Hsu Y-, Drake SK, Kim A, Wang W, Calvo KR, et al. Differential processing of high-molecular-weight kininogen during normal pregnancy. Rapid Commun Mass Spectrom. 2020;34 Suppl 1:e8552.

Witschen PM, Chaffee TS, Brady NJ, Huggins DN, Knutson TP, LaRue RS, et al. Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. 2020, , 1325. Cancers (Basel). 2020;12(10).